Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients

OBJECTIVES: Creatinine is the biomarker of choice for use in estimates of kidney function in oncology patients. However as non-renal factors such as muscle mass can influence creatinine concentrations, we evaluated cystatin C as an alternative biomarker and its incorporation in GFR estimating formul...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Melissa, Denieffe, Stephanie, Griffin, Ciara, Tinago, Willard, Fitzgibbon, Maria C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575377/
https://www.ncbi.nlm.nih.gov/pubmed/28856234
http://dx.doi.org/10.1016/j.plabm.2017.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575377/
https://www.ncbi.nlm.nih.gov/pubmed/28856234
http://dx.doi.org/10.1016/j.plabm.2017.05.005

Ejemplares similares